Skip to main navigation

Skip links

  • Skip to content
  • Skip to footer

Akari TX

Main navigation

Menu
  • Home
  • About
    • Company Overview
    • Management
    • Board of Directors
  • Areas of Focus
    • Pipeline
    • Science
    • HSCT-TMA
    • Nomacopan in HSCT-TMA
    • Geographic Atrophy (GA)
    • PAS-Nomacopan in GA
  • Investor Relations
    • Overview
    • General Meeting of Shareholders
    • Corporate Governance
      • Governance Overview
      • Board of Directors
      • Management
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Annual Reports
    • News & Presentations
      • Press Releases
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
    • Email Alerts
  • Press
    • Press Releases
    • Stories
  • Contact Us

EFFECT

SEC Filing Details

Document Details

Form
EFFECT
Filing Date
Oct 1, 2021
Document Date
Oct 1, 2021
Form Description
EFFECT
Filing Group
Other
Company
Akari Therapeutics
Issuer
AKARI THERAPEUTICS PLC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Tools
  • Print Page
  • Email Alerts
  • RSS Feeds
  • Contact Us

Footer

Follow Us

Terms of Use
Privacy Statement
Expanded Access
Contact Us

Akari TX

Copyright © 2023 Akari Therapeutics Plc. All rights reserved.